Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
144.4 USD | +0.26% | +11.48% | +22.19% |
Apr. 26 | CR Double-Crane Pharmaceutical's Profit Rises 11% in Q1 as Revenue Grows 2% | MT |
Apr. 26 | CR Double-Crane Pharmaceutical's Unit Gets Nod to Trial New Pain Medication | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.19% | 8.24B | |
+11.20% | 15.36B | |
-3.28% | 6.73B | |
+35.50% | 1.97B | |
+0.49% | 1.51B | |
+26.34% | 975M | |
+0.92% | 845M | |
+9.29% | 751M | |
-5.19% | 675M | |
-20.92% | 402M |
- Stock Market
- Equities
- CR Stock
- News Crane Company
- CR Double-Crane Pharma Gets Regulatory Nod to Amend Instructions for Lansoprazole for Injection